Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00073502 |
Date of registration:
|
21/11/2003 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
|
Scientific title:
|
A Phase II Study of Single Agent OSI-7904L In Patients With Locally Advanced or Metastatic Adenocarcinoma Of the Stomach or Gastroesophageal Junction |
Date of first enrolment:
|
October 2003 |
Target sample size:
|
43 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00073502 |
Study type:
|
Interventional |
Study design:
|
Primary Purpose: Treatment
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
Belgium
|
United Kingdom
|
United States
| | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Documented locally advanced or metastatic adenocarcinoma of the stomach or
gastroesophageal junction No prior chemotherapy for locally advanced or metastatic disease
Adequate baseline bone marrow, hepatic and renal function Age >= 18 years At least one
target lesion
Exclusion Criteria:
Active or uncontrolled infections or other serious illnesses or other medical conditions
(eg, hepatitis, HIV, chronic alcohol abuse) Symptomatic brain metastases which are not
stable
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Gastroesophageal Adenocarcinoma
|
Gastric Adenocarcinoma
|
Intervention(s)
|
Drug: OSI-7904L
|
Secondary ID(s)
|
OSI-904-201
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|